Radiopharm Theranostics L...

NASDAQ: RADX · Real-Time Price · USD
4.78
-0.23 (-4.69%)
At close: Aug 15, 2025, 2:14 PM
5.12
7.11%
After-hours: Aug 15, 2025, 05:49 PM EDT

Radiopharm Theranostics Balance Sheet Statement

Financials in AUD. Fiscal year is July - June.
Fiscal Year Q4 2023 Q4 2022 Q4 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022
Cash & Equivalents
18.58M 11.7M 26.98M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
40K 40K 40K
Receivables
987.41K 4.47M 56.48K
Inventory
n/a n/a n/a
Other Current Assets
3.29M 133.13K 228.82K
Total Current Assets
22.85M 16.3M 27.26M
Property-Plant & Equipment
60.8K 68.33K 1.58K
Goodwill & Intangibles
49.09M 58.54M 56.08M
Total Long-Term Assets
49.19M 58.65M 56.12M
Total Assets
72.04M 74.95M 83.38M
Account Payables
6.43M 2.96M 1.19M
Deferred Revenue
n/a n/a n/a
Short-Term Debt
n/a n/a n/a
Other Current Liabilities
6.72M 8.11M 5.73M
Total Current Liabilities
17.58M 13.23M 7.88M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
27.11M 16.14M 12.54M
Total Long-Term Liabilities
27.11M 16.14M 12.54M
Total Liabilities
44.68M 29.37M 20.42M
Total Debt
n/a n/a n/a
Common Stock
100.68M 97.23M 86.76M
Retained Earnings
-111.34M -65.35M -30.82M
Comprehensive Income
37.93M 10.36M 7.03M
Shareholders Equity
28.12M 44.38M 62.96M
Total Investments
n/a n/a n/a